Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
Aurora kinase-IN-10
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Aurora kinase-IN-10 is an inhibitor of Aurora kinases, exhibiting IC50 values of 5.94 nM for Aurora A and 86.06 nM for Aurora B. It possesses anti-tumor activity and can be utilized in studies related to cancers, such as triple-negative breast cancer. |
| Targets & IC50 | Aurora A:5.94 nM |
| In vitro | Aurora kinase-IN-10 (Compound 4q) effectively inhibits the proliferation of MDA-MB-231, A549, PC9, and LO2 cells, with IC50 values of 1.49, 19.44, 6.57, and 48.11 μM, respectively. In rat liver microsomes, its half-life is 126.6 minutes, and in rat plasma, it is approximately 18.3 hours. |
| In vivo | Aurora kinase-IN-10 (Compound 4q) (15 mg/kg; administered via intraperitoneal injection every other day for 20 consecutive days) demonstrates significant in vivo antitumor efficacy in the MDA-MB-231 xenograft mouse model. |
| Molecular Weight | 471.53 |
| Formula | C26H26FN7O |
| Cas No. | 3053885-69-8 |
| Smiles | N(C=1C2=C(C=C(C=C2)N3CCN(C(C)=O)CC3)N=C(/C=C/C4=CC=C(F)C=C4)N1)C5=NNC(C)=C5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.